Vytorin — Class II drug recall D-0007-2016
Terminated recall by Merck Sharp & Dohme, Wilson Facility, reported 2015-10-14, distributed in KY, MS, OH. Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg t
| Recall number | D-0007-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Merck Sharp & Dohme, Wilson Facility, Wilson, NC, United States |
| Recall initiated | 2015-08-14 |
| Classified | 2015-10-05 |
| Reported by FDA | 2015-10-14 |
| Terminated | 2016-05-04 |
| Distributed | KY, MS, OH |
| NDC | 66582-0312-82 |
| Lot numbers | L013425 |
| Expiration dates | 2016-11 |
Product
Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.
Reason for recall
Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0007-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.